Bronstein, Gewirtz & Grossman, LLC Announces Investigation of OCZ Technology Group, Inc.
NEW YORK, Oct. 11, 2012 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of OCZ Technology Group, Inc. ("OCZ" or the "Company") (NasdaqCM: OCZ), concerning potential violations of federal securities laws.
The investigation is related to allegations that certain statements issued by the Company between July 10, 2012 and October 10, 2012 concerning OCZ's business and financial performance were false and misleading. On October 10, 2012, Shares of OCZ dropped nearly 42% in premarket after the Company said it notified the Securities and Exchange Commission to extend its filing deadline for its second quarter, which ended Aug. 31, because its financial statements are under review. Also, the company announced in a press release that the "Q2'13 revenue will be materially lower than the September 5th preliminary revenue range of $110 to $120 million." It said the effects of the customer incentive programs were discovered after the company issued its latest guidance. Shares of the Company dropped $1.27 to close at $1.88 per share.
If you are aware of any facts relating to this investigation, or purchased shares of OCZ, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman , 212-697-6484
SOURCE Bronstein, Gewirtz & Grossman, LLC
More by this Source
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.
May 22, 2013, 16:05 ET
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iGATE Corporation
May 22, 2013, 08:30 ET
Bronstein, Gewirtz & Grossman, LLC Notifies Investors with Losses on Their Investment in Accretive Health, Inc. of Class Action Lawsuit and the Deadline to Seek a Lead Plaintiff Position
May 21, 2013, 16:05 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.